Article Details

CDSCO Panel grants Pfizer's protocol amendment proposal for Tofacitinib

Retrieved on: 2022-12-25 11:14:20

Tags for this article:

Click the tags to see associated articles and topics

CDSCO Panel grants Pfizer's protocol amendment proposal for Tofacitinib. View article details on hiswai:

Excerpt

This recommendation came after the drug major Pfizer presented protocol amendment 12 dated 06-05-2022 for protocol no A3921145 (Long-Term Safety ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up